Hemab Therapeutics, a clinical-stage biotech company focused on blood coagulation disorders, will announce its third quarter 2026 financial results and provide a corporate update on November 10, 2026. The company will host a conference call at 8:00 a.m. ET for investors and analysts, with a webcast available on its website. Hemab is developing innovative therapies for bleeding and thrombotic diseases, including treatments for Glanzmann thrombasthenia, Factor VII deficiency, Von Willebrand Disease, and heavy menstrual bleeding. This update is important for investors tracking the progress of Hemab's clinical programs and financial health.
Hemab Therapeutics' upcoming Q3 2026 financial results provide context for readers tracking biotech firms. For readers following the health sector, here is Pluang's market snapshot as of Nov 03, 2026 19:02 WIB: Among 150 priced US health stocks, 74 rose and 69 fell. Notably, COGT rose 2.86% to USD 30.58 with a typical hold time of 19 days, contrasting with BKD which fell 2.68% to USD 10.16 over the same hold period. ADMA Biologics gained 2.62% to USD 11.35, with balanced Pluang order activity and a slightly longer hold time of 20 days.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
